Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy science biotech

	Profile	Recent Articles on Subject
1	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 3 days ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 3 days ago STAT+: Pharmalittle: We’re reading about PBM practices, DOJ tussling with Regeneron, and more - about 2 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 2 months ago STAT+: Drug wholesaler owners indicted for alleged role in diverting Gilead and J&J HIV medicines - 3 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 6 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more - 6 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 7 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 7 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 7 months ago STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived - 7 months ago STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more - 7 months ago STAT+: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV - 7 months ago STAT+: Diabetes treatments have improperly listed patents that should be removed, analysis finds - 7 months ago STAT+: Pharmalittle: We’re reading about FDA’s syphillis-drug plan, India’s manufacturer-inspection demands, and more - 8 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 9 months ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - 9 months ago STAT+: Pharmalittle: Bluebird’s sickle-cell screwups may prompt a sale; drugmakers raised prices on widely used meds without new clinical evidence - 9 months ago STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds - 10 months ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - 10 months ago STAT+: FTC challenges several big drugmakers over inaccurate or improper patent listings - 10 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - 11 months ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - 11 months ago STAT+: Pharmalittle: Roche buys Roivant bowel disease drug for $7.1 billion; AstraZeneca CEO calls report of imminent retirement ‘fake news’ - 11 months ago STAT+: Pharmalittle: China arrests an Astellas exec accused of spying; weight-loss drugs are being tested in children - 11 months ago STAT+: Lilly complains to the U.S. International Trade Commission about unapproved versions of Mounjaro - 11 months ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - 12 months ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - 12 months ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - 12 months ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	Antiviral used for mpox no better than placebo, NIH says - about 1 month ago
4	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Buying shady weight loss drugs online is a bad idea, in case you were wondering - about 1 month ago CVS ditches common cold meds after FDA advisers say they’re useless - 11 months ago
5	Katie Palmer STAT News Health tech reporter @statnews. JSK Stanford alum. MA health technologysciencejournalism	Weight loss drugs without a prescription? Study warns it’s a ‘very risky business’ - about 2 months ago
6	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Will the real Ozempic please stand up? Lilly, Novo face uphill counterfeit battle - 3 months ago Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? - 4 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - 5 months ago
7	Deanna Fox, PharmD Pharmacy Times Former journalist. Now comms exec. Capital Region, New York communications	OTC Case Studies, Pain Management - 3 months ago OTC Case Studies: Winter Colds - 8 months ago
8	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Aspirin for Fatty Liver; Meds for Self-Managed Abortion - 6 months ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Issues Letters to 6 Companies for Unapproved, Misbranded OTC Analgesic Products - 6 months ago
10	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	These four common medicines could help prolong your life - 6 months ago

Journalists covering Pirated Medicine